Since aberrant activation of cGAS is implicated in several autoimmune diseases, senescence and tumorigenesis [16, 17, 39], it will be important to develop means to modulate cGAS activation based on the regulatory mechanisms. The gene discussed is CGAS; the disease is autoimmune disease.